Because the management of the company has zero credibility and every single long term holder is in the red.Put this stock on your screen, watch it and when they actually fix the balance sheet and generate some revenue,but it then. As a long term stuckholder, I know this is not in my best interet and I should be encouraging all to buy buy buy, but better to pay it forward. If Cytori is the real deal it will go much higher then $5 but as for now that seems pretty far fetched. Plenty of potential but you can't eat potential.
Think you been standing under the sprinkler too long and brain may be water logged but I'll take it to be done with this nightmare.
Your not really grasping the science Phillip the enzyme is used with the stem cells . Nobody will copy this machine. You should if you have not already listen to the last call and especially the Q7A at the end to give yourself a better understanding of what you have invested in. I also suggest you visit cytx-investordotcom where you can learn about the history of the company as well as learning from mostly knowlegeable long term investors. GL
Your a fool for going all in at one price. If your in for the long term sit back and buy on the dips. As I have said numerous times, you will not buy at the low or sell at the high and if Cytori becomes the company us long term stuckholders bought into years ago, $1.30 will be nothing. If your day trading good luck.
As the business model for Cytori has changed dramatically from a razor blade model to selling the finished stem cells , and if the FDA follows through on enforcement of all those using as YMB poster totaljim likes to say centrifuges, then this will be a bonaza for Cyttori. The new cellution machine is so advanced that Cytori can monitor the patient, the indication and the quality of the cells. As the government has been very involved in the development of the softwear that does this and being that the government is funding the development of the cellution machine, this is all making sense. The govenment want the most cash efficient way to get Cellution machines in hospitals and does not want to stockpile consumables so by purchasing the end product the cells to treat burns and for hospitals to use for other indications once approved, this new model works great and Cytori will be paid for the cells, which is great. Others wanting to use the cells will need to go through Cytori and the FDA can monitor the use, which is exactly what they want to do. IOutside the USA the razor blade model will work nicely. See Okyanos and the deal with Lorem vascular which will kick in if and when China approvals kick in. If you believ what Cytori tells us this willl be sooner rather then later.
Schwabb is doing it, Morgan stanley is not based on the the discussions I have had where I trade. That should tell you something right there. I would say it's also about time for one more negative article from Adam Fuerstein the pimp of the shorts to give them one more chance to cover, before all the hard work cytori has been doing pays off. Hopefully soon Cytori will be able to attract a capable CEO to finally take Cytori to the promised land. Don't begin holding your breath just yet. Today's news is a good baby step though. GLTA longs shorts GFY.
That is not a good strategy for longs. Do not allow your shares to be loaned out for the pennies you will get. Make the shorts buy on the open market. Whoever is lending out there shares is only helping the shorts.
Finally a product launch that may actually generate some revenue. Hope the launch of the cellution 2 machine is not far behind. get the balance sheet mess out odf the way and it maay be time to add to my overweighted, and in th red position, but not yet. I've heard the promises and prefer to pay up and wait for facts rather then fairy tale. Short position continues to grow so perhaps one last drop due to dilution until a solid advance in PPS. The shorts have been right so far. GLTA, the glass is half full at least.
Cytori Updates Investors on Recent FDA Draft Guidance on Cell Therapy and Adipose Tissue
This is very good news for Cytori
Just go to their homepage to read more, the following is just an small excerpt:
The draft guidelines contain several points worthy of highlight:
· The clinical use of cells isolated from human tissue, no matter the isolation process, and including cells derived from adipose tissue, will require FDA oversight.
· The process of extracting any cell population or cellular subset from adipose tissue will be considered beyond the technical process of ‘minimum manipulation’. Minimal manipulation means a process that does not change the relevant biological characteristics of a cell or tissue.
· The clinical use of an isolated cell population will not be considered exempt under the technical definition of ‘same surgical procedure’. The same surgical procedure exemption is important because it was the legal mechanism that allowed physicians to legally utilize cell isolates from tissue on the same patient. This exemption has now been redefined to require ‘minimum manipulation’ as a new requirement for the exemption.
· Adipose derived cellular products may be regulated through the investigational drug pathway (as a drug or biological product) or as a PMA device at the discretion of the FDA.
· Any party, in the US, extracting cells from adipose tissue for use as a therapeutic will be required to obtain a biologics license from FDA to commercialize the product or obtain approval for an IND or IDE to pursue a clinical investigation. Products with formal device designation from FDA are eligible to proceed to market through a PMA device pathway where device regulations are applied versus the very different pharmaceutical regulations.
· Physicians can no longer make their own cell therapies from adipose tissue without FDA oversight
AG your so off base with your focus on Athena data. There are many more near term catalysts. You should relisten to the call a bit closer.
Jim, just listen to the last call. For answer to your specific question go to the Q&A and you will here it explained. the business model has now changed from razor razor blade to a model that they will be selling the processed stem cell. The new machine is so advanced that it monitors the pattients data and checks the stemcells as well. This is how the FDA wants to control what the stemcells are used for,so that they are only used for authorized uses and patients. They are working very closely with the FDA. Differnt model outside the USA where they will sell the machines like at Okyanos, but due to FDA and there desire to control they arw working very closely with CYTX. Goebernment is paying a nice % of the development cost for the softwear tech that monitors all of this over and above BARDA $'s which has paid for development of table top model. This saves hospitals money as Cytori will place the machines and disposables and be paid for the actual cells. It's a very good listen and i think thismay actually change your opinion if of course they fix the balance sheet.
Jim it looks like all the centrifuges may have to be regulated and come through CTX2 machine at least in the USA if the FDA enforces what it says it will. That make CYTX centrifuge the best and you may have to stop bashing. All in due time.
I am not considering averaging down until the issues with the balance sheet are resolved.
For others that have yet to buy this could be a good place to begin accumulating. I do not think that CYTX is going to run away from anayone. Based on history I would reiterate that I am skeptical of anything I hear from Cytori. As for trading lower. I completely expected this as Cytori always does the opposite and is a completely manipulated stock for the benifit of investors like Sabby and the shorts. Don't believe the bs about share not avaible for shorting these guys are pro's and naked shorting is a way of life. The sceloderma trials are not even enrolled yet and won't be for a year so you need to really listen and not get caught up in the hype and half truths you hear. Hedrik was the best I ever heard him on this call and was much better when he was speaking without script then reading. I felt a genuine excitement in his voice which leads me to believe there was more truth then fairy tale in his words. The day traders are still in control and will be until there is verifiable news of a partnership. If the FDA actually enforces the rules they have set up with regard to Dr.s using any method to derive stem cells like a centrifuge as Hendrik says they will then we may one day enjoy a share price that is respectable. If your not day trading this is a long term highly speculative play.
one might think that. your a bit overly optimistic, usually when you expect one thing the opposite happens with Cytori. You would hear no complaints from me if the trend is broken with the "suppsoedly New Cytori"
Hair growth revenue is a long way off and not a concern. What was a red flag to me was no mention of revenue stream from Okyanos. This is second call where there was zero mention. This was always a big focus in calls and if history repeats itself, when management stops talking about a subject it tends to fall into the abyss like breast reconstruction ,and Japan actually generating revenue. Overall call was good if you are new investor just being introduced to Cytori it sounds like a great story and sure fire winner. History and the size of my losses and the losses of ALL long term holders leave us cautiously optimistic. If you have no skin in the game at a buck and change a great entry point if company gets financing in order without too much more dilution. I'll wait and see concrete results, won't mind aveaging down would be alot happier entering here then when I did.GLTA longs shorts can GFT.
You have way overstated what the FDA has done. The trial is in an initial phase and it will be years before we se any $'s from Sceloderma.
Rodney just join the board cytori-investordotcom. As to your comments Cytori has been manipulated for as long as i have held, and that is going on 5 years. The shorts control the stock and continue to do so. The only thing that is going to get CYTX from the grips of the shorts is if they execute which they have failed to do. Lorem vascular has done zero, not even a website in place, which in itself is pretty pathetic. Sales revenue from japan has been nill, which is disapointing considering that management has been telling investors for years that because Cytori has been so well positioned in japan for years that the passage of legislation would have immediate impact. Not happening, it's been a year and nothing to show for it. BARDA promises money which Cutori says will be used for development of next generation Cellution machine and then they announce delay. They promise revenue from Okyanos and we have nothing to show for it. China approvals, is the next big lie as revenue here would be generated by lorem and we have not as I said had an update in a year. The call this afternoon will only serve to reinforce what they disclosed at the last conference call which was broadcast and that is a revenue miss. Techiicals mean nothing except to the day traders that
have overun this message board . Nothing has changed at Cytori except for layoffs and continued cost cutting, due to the hundreds of millions they have wasted paying themselves for incompetency for all these years. Whats the definition of insanity. Doing the same thing over and over and expecting a different result. IMHO Cytori's inability to execute on anything has left us in the pathetic position we are in. I guess if you are newbie and bought at .47. then you are feeling good, but there is not a single long term shareholder other then management who get there shares for free who is in a profitable position here.
you don't need to go to a chat room all the pumpers are here and they have over run the site with BS. Great for daytraders